Skip to main content
Toggle navigation
Login
Search
Home
Tweets by 2023 SSO Annual Meeting
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Melanoma
Home
Melanoma
Melanoma
Type here to filter the list
E217: Treatment Resistance to melanoma Therapeutics on a Single Cell Line
Favorite
E218: A Conserved Gene Signature Correlates with Melanoma Treatment Response in Patient Tumors and Blood
Favorite
E219: Real-World Safety and Efficacy of Talimogene Laherparepvec Therapy in Older Adults with Advanced Melanoma
Favorite
E220: Surgery and Radiotherapy Can Successfully Salvage Isolated Lymph Node Field Recurrence After Lymphadenectomy in Patients with Melanoma
Favorite
E221: Impact of Perioperative Antibiotic Prophylaxis on the Microbiome in Patients with Cutaneous Malignancy
Favorite
E222: Impact of Social Vulnerability on Melanoma Nodal Surveillance: A Multi-Institutional Study
Favorite
E223: Clinical Outcomes of Patients with Primary Dermal Cutaneous Melanoma
Favorite
E224: Delay in surgery negatively impacts patients with early stage node-negative Merkel Cell Carcinoma
Favorite
E225: Melanoma in Black Patients: Distinct Presentation Can Inform Strategies to Improve Outcomes
Favorite
E226: Primary Melanoma Tumor Infiltrating Lymphocytes (TILs) as a Predictor for Immunotherapy Response
Favorite
E227: Spatial Transcriptomics and Deep Learning Capture Melanoma Clonal Evolution During the Acquisition of Resistance to Targeted Treatment
Favorite
E228: Survival and Postoperative Complications After Metastasectomy for Stage IV Melanoma
Favorite
E229: Is It Time for Synoptic Reporting in Melanoma Nodal Surveillance Ultrasonography?
Favorite
E230: Management of primary anorectal mucosal melanoma in the era of modern systemic immunotherapy and targeted therapy
Favorite
E231: The impact of mesenchymal transition and macrophage phenotype in immunotherapy-resistant melanoma
Favorite
E232: A novel lentivirus generates erbb2 (HER2/neu) as a neoantigen target for NK antibody-dependent cell-mediated cytotoxicity in melanoma
Favorite
E233: Rural Melanoma Patients Have Less Surgery and Higher Melanoma-Specific Mortality
Favorite
E234: Machine Learning Algorithms for Predicting Sentinel Node Status in Melanoma: Implications for Predictive Biomarker Modeling
Favorite
E235: Are racial and ethnic minorities with low income associated with late-stage presentation of non-ocular cutaneous melanoma at diagnosis?
Favorite
E236: Clinical predictors of sentinel node positivity in melanoma: a non-invasive means of identifying patients who may benefit from adjuvant immunotherapy
Favorite
E237: Merkel Cell Polyomavirus Expression in Tumor and Plasma of Patients with Merkel Cell Carcinoma
Favorite
E238: Immediate lymphatic reconstruction for the prevention of lymphedema following lymphadenectomy in melanoma and soft tissue malignancy
Favorite
E239: Less is More: Adjuvant Immunotherapy Can Be Avoided in Elderly Patients with Low-Risk Stage IIIA Melanoma
Favorite
E240: Role of Wide Local Excision in Cutaneous Melanoma with Margin Negative Biopsies
Favorite
E241: Treatment Trends in utilization of immunotherapy for stage III melanoma in the US between 2010-2019: A Retrospective Analysis using the National Cancer Database
Favorite
E242: Association Between History of Viral Infections and Risk of Melanoma
Favorite
E243: Evaluating the role of level 3 axillary lymph node dissection in metastatic melanoma: can we predict involvement?
Favorite
E244: Validation of the i31-GEP for sentinel lymph node biopsy metastasis in patients with T1b-T2a cutaneous melanoma: Results of an independent performance study
Favorite
E245: Impact of Demographic and Socioeconomic Factors on the Receipt of Immunotherapy for Stage III Melanoma
Favorite
P41: A Multi-Institution Observational Analysis of the Theory of the Immunization Effect in Patients with Multiple Primary Melanomas
Favorite
P42: Clinical Benefit of Sentinel Lymph Node Biopsy Nomograms for Head and Neck Melanoma
Favorite
P43: Prognostic assessment of sentinel lymph node metastases: Are we using the wrong measure of tumor burden?
Favorite
P44: A Tool For Predicting The Risk Of Death From Melanoma And Competing Causes At Varying Time Intervals After Diagnosis
Favorite
P45: Dietary fish oil impairs melanoma growth and augments the tumor immune microenvironment in anti-PD-1 treated melanoma
Favorite
P46: Histotripsy ablation abrogates tumor hypoxia and induces immunogenic cancer cell death
Favorite
P47: Predicting recurrence after a negative sentinel lymph node in melanoma: the model changes with time and sites of recurrence
Favorite
P48: Increased Frequency of Gene Mutations Significantly Decreases Recurrence Risk In High-Risk Stage II Melanoma Patients.
Favorite